OSUR OraSure Technologies, Inc. Stock Quote

Your browser is no longer supported. Please, upgrade your browser.

publish chart | save to portfolio | create alert

Settings

OSUR [NASD]

OraSure Technologies, Inc.

Healthcare | Medical Instruments & Supplies | USA

statements

Index	-	P/E	55.74	EPS (ttm)	0.20	Insider Own	1.70%	Shs Outstand	61.93M	Perf Week	-17.39%
Market Cap	697.30M	Forward P/E	-	EPS next Y	-0.03	Insider Trans	0.00%	Shs Float	60.99M	Perf Month	-27.54%
Income	12.60M	PEG	2.79	EPS next Q	-0.08	Inst Own	93.00%	Short Float	5.72%	Perf Quarter	81.91%
Sales	156.10M	P/S	4.47	EPS this Y	527.00%	Inst Trans	-3.56%	Short Ratio	2.70	Perf Half Y	40.57%
Book/sh	4.69	P/B	2.40	EPS next Y	85.70%	ROA	3.80%	Target Price	14.00	Perf Year	31.70%
Cash/sh	2.68	P/C	4.20	EPS next 5Y	20.00%	ROE	4.20%	52W Range	5.23 - 18.27	Perf YTD	40.22%
Dividend	-	P/FCF	278.92	EPS past 5Y	39.30%	ROI	4.50%	52W High	-38.37%	Beta	0.49
Dividend %	-	Quick Ratio	7.60	Sales past 5Y	7.70%	Gross Margin	59.40%	52W Low	115.30%	ATR	1.18
Employees	472	Current Ratio	8.50	Sales Q/Q	5.00%	Oper. Margin	9.20%	RSI (14)	33.92	Volatility	8.28% 7.65%
Optionable	Yes	Debt/Eq	0.01	EPS Q/Q	-123.50%	Profit Margin	8.10%	Rel Volume	5.85	Prev Close	12.11
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 06 AMC	Payout	0.00%	Avg Volume	1.29M	Price	11.26
Recom	3.00	SMA20	-26.28%	SMA50	-15.38%	SMA200	25.70%	Volume	7,558,676	Change	-7.02%

Apr-21-20

Resumed

Stephens

Equal-Weight

$14

Oct-23-18

Resumed

Raymond James

Mkt Perform

Jul-16-18

Downgrade

Stephens

Overweight → Equal-Weight

Nov-02-17

Downgrade

Jefferies

Buy → Hold

Feb-09-17

Upgrade

Raymond James

Mkt Perform → Outperform

Jun-13-16

Downgrade

Raymond James

Outperform → Mkt Perform

Nov-05-15

Reiterated

Mizuho

Buy

$12 → $8

May-07-15

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Jan-23-15

Reiterated

Mizuho

Buy

$10 → $12

Jun-12-14

Reiterated

Canaccord Genuity

Buy

$10 → $11

Jun-11-14

Reiterated

Mizuho

Buy

$9 → $10

Dec-21-12

Initiated

Mizuho

Buy

Aug-08-12

Upgrade

Barrington Research

Mkt Perform → Outperform

$12.50

Jul-05-12

Downgrade

Barrington Research

Outperform → Mkt Perform

Mar-27-12

Initiated

JMP Securities

Mkt Outperform

$15

Mar-21-12

Upgrade

MLV & Co

Hold → Buy

$11 → $13

Feb-09-12

Downgrade

MLV & Co

Buy → Hold

$11

Jul-01-11

Resumed

Barrington Research

Outperform

$10

Nov-30-10

Initiated

Barrington Research

Outperform

Nov-16-10

Initiated

Canaccord Genuity

Buy

Jun-02-20 11:15PM	OraSure Technologies, Inc. Prices Underwritten Offering of Common Stock GlobeNewswire -14.24%
Jun-01-20 04:01PM	OraSure Technologies, Inc. Announces Proposed Public Offering of Common Stock GlobeNewswire
May-29-20 07:00AM	OraSure Technologies, Inc. Announces Purchase of UrSure, Inc. GlobeNewswire +7.62%
06:00AM	OraSure Technologies Appoints Lelio Marmora to Board of Directors GlobeNewswire
May-26-20 06:00AM	OraSure Technologies to Present at the Jefferies 2020 Healthcare Conference GlobeNewswire
May-22-20 07:00AM	OraSures OMNIgene®·ORAL Kit Included in EUA Granted to P23 Labs for At-Home Collection of Saliva Samples for SARS-CoV-2 Test GlobeNewswire
06:00AM	Diversigen Inc. Selected by Nom Nom as the Preferred Provider for Metagenomics and Microbiome Sequencing and Analysis Services GlobeNewswire
May-15-20 06:00AM	OraSure Technologies to Present at the UBS Virtual Global Healthcare Conference GlobeNewswire
May-14-20 06:00AM	OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 19, 2020 GlobeNewswire
May-12-20 08:00AM	OraSure Technologies, Inc. Consolidates Microbiome Services Subsidiaries GlobeNewswire
May-07-20 10:31AM	OraSure Technologies (OSUR) Q1 2020 Earnings Call Transcript Motley Fool
07:29AM	Edited Transcript of OSUR earnings conference call or presentation 6-May-20 9:00pm GMT Thomson Reuters StreetEvents
May-06-20 04:00PM	OraSure Announces 2020 First Quarter Financial Results and Provides COVID-19 Update GlobeNewswire +5.17%
May-05-20 06:00AM	OraSure Technologies Appoints Lisa Nibauer as Infectious Disease Business Unit Lead GlobeNewswire
May-04-20 06:00AM	DNA Genoteks ORAcollect®·RNA kit included in EUA granted to Biocerna SARS-CoV-2 test GlobeNewswire
May-02-20 10:56AM	Can You Imagine How Jubilant OraSure Technologies' (NASDAQ:OSUR) Shareholders Feel About Its 173% Share Price Gain? Simply Wall St.
Apr-29-20 12:33PM	Earnings Preview: OraSure Technologies (OSUR) Q1 Earnings Expected to Decline Zacks
Apr-09-20 06:00AM	OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Apr-08-20 01:18PM	Lehigh Valley medical device company working on at-home COVID-19 test American City Business Journals
06:00AM	OraSure Technologies Appoints David J. Shulkin, M.D. to Board of Directors GlobeNewswire
Apr-06-20 06:00AM	OraSure Technologies Receives BARDA Contract for Rapid Oral Fluid Pan-SARS-Coronavirus In-home Self-test GlobeNewswire +7.76%
Apr-02-20 09:35AM	OraSure Technologies (OSUR) in Focus: Stock Moves 7.6% Higher Zacks -9.50%
Mar-27-20 07:20AM	What Is OraSure Technologies's (NASDAQ:OSUR) P/E Ratio After Its Share Price Rocketed? Simply Wall St.
Mar-19-20 09:17AM	Should OraSure Technologies, Inc. (NASDAQ:OSUR) Focus On Improving This Fundamental Metric? Simply Wall St. +6.19%
Feb-26-20 06:00AM	OraSure Technologies to Present at the Raymond James 41st Annual Institutional Investors Conference GlobeNewswire
01:09AM	Edited Transcript of OSUR earnings conference call or presentation 19-Feb-20 10:00pm GMT Thomson Reuters StreetEvents
Feb-21-20 10:04AM	Earnings Miss: OraSure Technologies, Inc. Missed EPS By 10.0% And Analysts Are Revising Their Forecasts Simply Wall St.
07:46AM	The Daily Biotech Pulse: FDA Approves Baudax Bio's Non-Opioid Pain Drug, Aerie Rallies On Q4 Results, D-Day For Esperion Benzinga
Feb-20-20 07:06AM	The Daily Biotech Pulse: Heron Pain Drug Review Extended, Disappointment For Teva In Tourette Syndrome Study Benzinga -13.90%
Feb-19-20 05:15PM	OraSure Technologies (OSUR) Lags Q4 Earnings Estimates Zacks +8.37%
04:00PM	OraSure Announces 2019 Full Year and Fourth Quarter Financial Results GlobeNewswire
Feb-12-20 12:31PM	Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for Zacks
Jan-30-20 08:50AM	How Does OraSure Technologies, Inc. (NASDAQ:OSUR) Affect Your Portfolio Volatility? Simply Wall St.
Jan-29-20 12:31PM	Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for Zacks
06:00AM	OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Jan-22-20 06:00AM	DNA Genotek Announces FDA General Use Clearance for Oragene®·Dx Family of Products GlobeNewswire
Jan-08-20 06:00AM	OraSure Technologies to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Jan-07-20 12:21PM	Is OraSure Technologies, Inc. (NASDAQ:OSUR) Investing Your Capital Efficiently? Simply Wall St.
Dec-17-19 09:00AM	Prescient Metabiomics and CoreBiome collaborating to develop breakthrough colon cancer screening test PR Newswire
06:00AM	OraSure Technologies Announces 2020 Annual Meeting Date GlobeNewswire
Dec-10-19 12:42PM	Is It Too Late To Consider Buying OraSure Technologies, Inc. (NASDAQ:OSUR)? Simply Wall St.
Dec-09-19 06:13PM	Is OraSure Technologies, Inc. (OSUR) A Good Stock To Buy ? Insider Monkey
Nov-28-19 01:22AM	Edited Transcript of OSUR earnings conference call or presentation 6-Nov-19 10:00pm GMT Thomson Reuters StreetEvents
Nov-26-19 08:00AM	OraSure Technologies to Commemorate World AIDS Day by Ringing NASDAQ Opening Bell GlobeNewswire
06:00AM	OraSure Technologies to Present at the Piper Jaffray 31st Annual Healthcare Conference GlobeNewswire
Nov-06-19 08:15PM	OraSure Technologies (OSUR) Q3 Earnings Surpass Estimates Zacks
04:05PM	OraSure Announces 2019 Third Quarter Financial Results GlobeNewswire
04:00PM	OraSure Technologies, Inc. Announces Purchase of Diversigen GlobeNewswire
06:00AM	OraSure Technologies to Present at Stephens 2019 Nashville Investment Conference GlobeNewswire
Oct-31-19 10:28AM	Do You Like OraSure Technologies, Inc. (NASDAQ:OSUR) At This P/E Ratio? Simply Wall St.
Oct-30-19 10:33AM	Earnings Preview: OraSure Technologies (OSUR) Q3 Earnings Expected to Decline Zacks
Oct-28-19 06:00AM	OraSure Technologies Announces Support for New Federal Oral Fluid Drug Testing Guidelines GlobeNewswire
Oct-22-19 06:00AM	OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Oct-08-19 12:07PM	Did You Manage To Avoid OraSure Technologies's (NASDAQ:OSUR) 49% Share Price Drop? Simply Wall St.
Sep-12-19 11:26AM	Is OraSure Technologies, Inc.'s (NASDAQ:OSUR) ROE Of 6.8% Concerning? Simply Wall St.
Aug-20-19 07:44AM	Is OraSure Technologies, Inc. (NASDAQ:OSUR) A Volatile Stock? Simply Wall St.
Aug-19-19 08:00AM	OraSure Announces Sale of Cryosurgical Systems Business GlobeNewswire
Aug-14-19 09:00AM	Orasure Technologies Appoints James a. Datin to Its Board of Directors GlobeNewswire -5.02%
04:25AM	Edited Transcript of OSUR earnings conference call or presentation 6-Aug-19 9:00pm GMT Thomson Reuters StreetEvents
Aug-07-19 09:24AM	OraSure Technologies (OSUR) Q2 2019 Earnings Call Transcript Motley Fool
Aug-06-19 06:15PM	OraSure Technologies (OSUR) Q2 Earnings Top Estimates Zacks
04:00PM	OraSure Announces 2019 Second Quarter Financial Results GlobeNewswire
Jul-31-19 06:00AM	Orasure Technologies to Present at the 39th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-30-19 10:38AM	Earnings Preview: OraSure Technologies (OSUR) Q2 Earnings Expected to Decline Zacks
Jul-28-19 09:16AM	Do OraSure Technologies's (NASDAQ:OSUR) Earnings Warrant Your Attention? Simply Wall St.
Jul-25-19 06:00AM	OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Jul-10-19 06:20AM	Are Insiders Buying OraSure Technologies, Inc. (NASDAQ:OSUR) Stock? Simply Wall St.
Jun-26-19 05:00PM	OraSure Technologies and Others Join Forces for HIV Testing Day GlobeNewswire
Jun-22-19 09:19AM	Interested In OraSure Technologies, Inc. (NASDAQ:OSUR)? Here's What Its Recent Performance Looks Like Simply Wall St.
09:16AM	Want To Invest In OraSure Technologies, Inc. (NASDAQ:OSUR)? Here's How It Performed Lately Simply Wall St.
Jun-14-19 04:00PM	UPDATE - OraSure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference GlobeNewswire
Jun-13-19 06:00AM	Orasure Technologies to Present at Raymond James 2019 Life Sciences and MedTech Conference GlobeNewswire
Jun-11-19 04:35PM	Is OraSure Technologies, Inc. (OSUR) A Good Stock To Buy? Insider Monkey
Jun-07-19 08:21AM	Edited Transcript of OSUR earnings conference call or presentation 8-May-19 9:00pm GMT Thomson Reuters StreetEvents
Jun-04-19 08:07AM	Is There Now An Opportunity In OraSure Technologies, Inc. (NASDAQ:OSUR)? Simply Wall St.
May-29-19 06:00AM	OraSure Technologies to Present at Jefferies 2019 Healthcare Conference GlobeNewswire
May-17-19 07:46AM	Read This Before You Buy OraSure Technologies, Inc. (NASDAQ:OSUR) Because Of Its P/E Ratio Simply Wall St.
May-15-19 06:00AM	OraSure Technologies to Present at UBS Global Healthcare Conference GlobeNewswire
May-14-19 06:00AM	OraSure Technologies to Hold Virtual Annual Meeting of Stockholders on May 21, 2019 GlobeNewswire
May-09-19 11:23AM	OraSure Technologies (OSUR) Q1 2019 Earnings Call Transcript Motley Fool -8.00%
May-08-19 06:25PM	OraSure Technologies (OSUR) Reports Q1 Loss, Tops Revenue Estimates Zacks
05:12PM	OraSure: 1Q Earnings Snapshot Associated Press
04:00PM	OraSure Announces 2019 First Quarter Financial Results GlobeNewswire
01:30PM	CryoConcepts Receives FDA Clearance on Two Cryosurgical Devices for the Physician Office Market PR Newswire
May-05-19 08:16PM	Heres What Hedge Funds Think About OraSure Technologies, Inc. (OSUR) Insider Monkey
May-01-19 10:33AM	Analysts Estimate OraSure Technologies (OSUR) to Report a Decline in Earnings: What to Look Out for Zacks
Apr-30-19 07:24AM	Estimating The Intrinsic Value Of OraSure Technologies, Inc. (NASDAQ:OSUR) Simply Wall St.
Apr-25-19 08:00AM	CoreBiome Announces Leading Microbiome Researcher Rob Knight as Scientific Advisor Business Wire
Apr-17-19 06:00AM	OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Apr-11-19 01:37PM	OraSure Technologies, Inc. (NASDAQ:OSUR): Immense Growth Potential? Simply Wall St.
Mar-15-19 03:01PM	OraSure Technologies (NASDAQ:OSUR) Shareholders Have Enjoyed A 54% Share Price Gain Simply Wall St.
Mar-07-19 08:25AM	Why OraSure Stock Lost 16% in February Motley Fool
Feb-27-19 06:00AM	OraSure Technologies to Present at the Raymond James 40th Annual Institutional Investors Conference GlobeNewswire
Feb-20-19 02:35PM	Will OraSure Technologies, Inc.s (NASDAQ:OSUR) Earnings Grow In The Years Ahead? Simply Wall St.
Feb-08-19 07:34AM	Edited Transcript of OSUR earnings conference call or presentation 6-Feb-19 10:00pm GMT Thomson Reuters StreetEvents +12.67%
Feb-06-19 09:41PM	OraSure Technologies Inc (OSUR) Q4 2018 Earnings Conference Call Transcript Motley Fool
06:25PM	OraSure Technologies (OSUR) Surpasses Q4 Earnings and Revenue Estimates Zacks
05:34PM	OraSure: 4Q Earnings Snapshot Associated Press
04:00PM	OraSure Announces 2018 Full Year and Fourth Quarter Financial Results GlobeNewswire
03:00PM	OraSure Technologies, Inc. to Host Earnings Call ACCESSWIRE

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. The company operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company's principal products include OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, and OraSure QuickFlu Rapid Flu A&B test; OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; tuberculosis products; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D. saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND services, a suite of genomic services. In addition, the company manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was founded in 2000 and is based in Bethlehem, Pennsylvania.

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience